ANEB-001

• Description :

  ANEB-001 is an orally active CB1 inhibitor, can be used to research acute cannabinoid intoxication[1].

• UNSPSC :

  12352005

• Target :

  Cannabinoid Receptor

• Type :

  Reference compound

• Related Pathways :

  GPCR/G Protein; Neuronal Signaling

• Applications :

  Neuroscience-Neuromodulation

• Field of Research :

  Neurological Disease

• Assay Protocol :

  https://www.medchemexpress.com/aneb-001.html

• Purity :

  99.73

• Solubility :

  10 mM in DMSO

• Smiles :

  CC(C)(C)NC(N(C1)CC1O[C@H](C2=CC=C(C=C2)Cl)C3=C(C=CC=C3)C(F)(F)F)=O

• Molecular Formula :

  C22H24ClF3N2O2

• Molecular Weight :

  440.89

• References & Citations :

  [1]Joseph Fenton Lawler, et al. Formulations and methods for treating acute cannabinoid overdose. US11141404B1

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Reference compound1

• Clinical Information :

  Phase 2

• Isoform :

  CB1

• CAS Number :

  [791848-71-0]